A pharma giant expresses interest in a Stamford biotech company after striking a deal worth up to $1.3 billion for a New ...

Biogen has offered to buy all the shares in Sage Therapeutics ... slipped a little under 2%. Merck KGaA has acknowledged that it is in talks to buy US cancer SpringWorks, but cautioned there ...

Shares rose almost 15% on the Parkinson's data. Merck KGaA has acknowledged that it is in talks to buy US cancer SpringWorks, but cautioned there is no guarantee a deal will be forthcoming.

As of February 11 at 1:47:43 PM EST. Market Open.

As of February 10 at 3:27:42 PM EST. Market Open.